TRIB1 knockdown has also been shown to sensitise MCF7 cells to nutlin-3 treatment [39] and to sensitise various triple-negative breast cancer cell lines, including MDA-MB-231 cells, to TRAIL-induced apoptosis [21], further implicating TRIB1 in drug response in breast cancer. This evidence concerns the gene TRIB1 and triple-negative breast carcinoma.